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Abstract
Background: To provide indicators for the likelihood of sperm retrieval in patients undergoing testicular sperm
extraction is a major issue in the management of male infertility by TESE. The aim of our study was to determine
the impact of different parameters, including testicular histopathology, on sperm retrieval in case of reoperation in
patients undergoing testicular sperm extraction.
Methods: We retrospectively analyzed 486 patients who underwent sperm extraction for intracytoplasmic sperm
injection and testicular biopsy. Histology was classified into: normal spermatogenesis; hypospermatogenesis (reduction
in the number of normal spermatogenetic cells); maturation arrest (absence of the later stages of spermatogenesis);
and Sertoli cell only (absence of germ cells). Semen analysis and serum FSH, LH and testosterone were measured.
Results: Four hundred thirty patients had non obstructive azoospermia, 53 severe oligozoospermia and 3
necrozoospermia. There were 307 (63%) successful sperm retrieval. Higher testicular volume, lower levels of
FSH, and better histological features were predictive for sperm retrieval. The same parameters and younger age were
predictive factors for shorter time for sperm recovery. After multivariable analysis, younger age, better semen parameters,
better histological features and lower values of FSH remained predictive for shorter time for sperm retrieval while better
semen and histology remained predictive factors for successful sperm retrieval. The predictive capacity of a score
obtained by summing the points assigned for selected predictors (1 point for Sertoli cell only, 0.33 points for
azoospermia, 0.004 points for each FSH mIU/ml) gave an area under the ROC curve of 0.843.
Conclusions: This model can help the practitioner with counseling infertile men by reliably predicting the chance of
obtaining spermatozoa with testicular sperm extraction when a repeat attempt is planned.
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Background
The testicular biopsy has been for years one of the
crucial investigations in the diagnosis and management
of male infertility [1]. The advent of intracytoplasmic
sperm injection (ICSI) made possible successful assisted
reproduction with sperm derived from the testis in
patients with non-obstructive azoospermia (NOA)
through techniques of testicular sperm extraction
(TESE). One of the major challenge with conventional
TESE (cTESE) was to find indicators of the likelihood to
recover spermatozoa. From time to time, circulating
hormonal markers, testicular ultrasound and testicular
biopsy have been used [2]. None of these procedures has
proved particularly effective because often, due to the
profound heterogeneity of the testicular tissue, sperm-
atozoa were recovered even in the presence of indicators
suggestive for adverse outcomes. Nevertheless, biopsy
still seemed to be the best predictor of sperm recovery
(SR). A further reduction in the use of forecasting tech-
niques occurred with the advent of micro TESE
(mTESE). Many groups have argued that the mTESE
provides such a high SR compared to other techniques,
even in case of severe histological diagnosis like agenesis
of the germinal line, that cTESE and as a logical conse-
quence all the procedures to predict the chances of SR,
were put aside as techniques of historical interest not
relevant to current reproductive technologies [3–7].
However, besides recent studies have questioned the
superiority of mTESE compared to cTESE in the resili-
ence of the sperm retrieved [8, 9], the question of being
able to provide the patient and the doctor with a system
to assess the likelihood of recovering sperm in cases of
NOA retains all its meaning, particularly when a reinter-
vention following an unsuccessful sperm retrival attempt
is requested. Here we investigated retrospectively the
correlations between clinical, laboratory, demographic
characteristics, histolgical features and cTESE sperm
retrieval outcomes. Predictive values of each one of these
characteristics in the SR were scrutinized with the aim
of providing elements to make a choice as conscious as
possible in case of reintervention.
Methods
Four hundred eighty-six patients referring to the Centre
for Reproductive Medicine, of the European Hospital
(Rome, Italy) between january 2005 and june 2016,
retrospectively identified to have undergone cTESE and
ICSI, were studied. Concurrently with TESE all patients
were subjected to testicular biopsy for histological ana-
lysis. All patients had a semen sample evaluated in at
least two different occasions according to the WHO cri-
teria [10]. Azoospermia was diagnosed when the absence
of sperm was observed after 600 g centrifugation and
screening at 400× magnification. Cryptozoospermia was
one of the conditions considered under the spectrum of
NOA [11], defined as the absence of spermatozoa in
fresh semen preparations but rare sperm in a centrifuged
pellet [10]. Cryptozoospermia occurrence is attributed to
fluctuations in spermatogenesis in cases of NOA [11].
Oligozoospermia and necrozoospermia were defined as
less than 15 million sperm/ml and less than 5% viable
spermatozoa in the ejaculate, respectively. Oligozoosper-
mic patients were submitted to TESE after multiple ICSI
failure with poor embryo quality and repeated implant-
ation failure using motile ejaculatory spermatozoa on
the basis of the reported better outcome in selected se-
vere oligozoospermic patients when testicular spermato-
zoa were used [12].
A clinical history was recorded, including history of un-
descended testis, mumps orchitis, previous genito-urinary
infection, radiotherapy, chemotherapy, surgical procedures
or exposure to gonadotoxins. A clinical examination in-
cluded secondary sexual characteristics, testicular size
(measured with a Prader’s orchidometer) and consistency,
epididymal distension and varicocele. All patients had their
serum follicle stimulating hormone (FSH), luteinizing hor-
mone (LH) and testosterone (T) concentrations measured
without any hormonal medical therapy within 2 months
before cTESE. Karyotype and Y-chromosomal microdele-
tion analysis were performed on all patients. Patients with
AZFa, AZFb, AZFab, AZFbc, AZFabc microdeletions
were excluded.
Surgical technique
The surgical procedure was performed under general
anesthesia. After scrotal disinfection, the spermatic cord
and the scrotal skin were infiltrated with 8 ml of 7.5 mg/ml
ropivacaine hydrochloride (Norepine, ASTA, Milan, Italy).
The testicle on which the procedure was started was the
one with larger volume. For cTESE, a small (5 mm) equa-
torial horizontal incision of the albuginea with extrusion of
the testicular parenchima and scissors biopsy of approxi-
mately 5x2x3mm were performed. If no sperm was found,
multiple conventional superficial biopsies (4–8 sampling)
on the contralateral testicle was performed following the
same procedure. A fragment of the testis removed from the
testis used for the cTESE was processed for histology (see
below). The surgical procedure was always performed by
the same surgeon (GF) and the specimen processed by the
same biological team. The time required to find sperm in
the tissue was recorded.
Histology
A fragment of testicular parenchyma (2x2x2 mm) re-
moved from the testis used for cTESE procedure was
washed in buffered medium (Quinn’s Advantages Medium
with HEPES, SAGE, Cooper Surgical, Pasadena, USA)
with 2.5% human serum albumin (HSA, Albutein, Alpha
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Therapeutic Milan, Italy), fixed in Bouin’s solution (1 ml)
and sent to the pathology laboratory. All histological
examinations were performed by the same pathologist.
Based on the histopathological pattern, testicular histology
was classified into: normal spermatogenesis (NormoS);
hypospermatogenesis (HypoS, i.e. a reduction in the num-
ber of normal spermatogenetic cells); maturation arrest
(MA, i.e. an absence of the later stages of spermatogen-
esis); and Sertoli cell only (SCO, i.e. the absence of germ
cells).
Statistical analysis
Data are presented as mean ± standard deviation or
median ± inter quartile range for non-symmetric con-
tinuous variables, and as counts and percentages for
categorical ones.
The binary outcome (successful SR) was associated
with potential predictors through logistic regression,
with a Firth bias-reducing correction. The time-to-event
outcome (time to successful SR) was associated with
potential predictors through (univariate and multivari-
able) Cox regression modeling. In case of unsuccessfull
SR, time-to-event was censored as the time spent on un-
successful searching. Both for binary and time-to-event
outcomes, the final multivariable model was selected by
via forward-stagewise selection, based on Akaike Informa-
tion Criterion (AIC) [13]. All potential predictors were ini-
tially considered for inclusion in the multivariable model,
but only those leading to significant decrease in AIC (as
sequentially considered) were finally included.
The final multivariable linear logistic regression model
was used to build a score for successful SR. The points
assigned to each indicator or unit for continuous predic-
tors were obtained by rounding regression coefficients.
The score obtained was evaluated by means of a receiver
operating curve (ROC) analysis for a final model. The area
under a curve (AUC) is a measure of predictive power.
The value of 0.5 means that predictions are no better than
random guessing and the value of 1.0 indicates a (theoret-
ically) perfect test (i.e., 100% sensitive and 100% specific).
A p < 0.05 was considered as statistically significant and all
tests were two-sided. All statistical analyses were per-
formed with the software R version 3.2.0.
Results
The present study includes 486 patients with a mean age
of 37.2 ± 6.5 years (range 20–71 years): 430 with NOA
(40 with cryptozoospermia), 53 severe oligozoospermic
men who had previously failed to achieve paternity with
assisted reproductive technology procedures and 3
with necrozoospermia.
In the NOA group, the mean patient age was 37.2 ±
6.6 years (range 20–71 years); in the severe oligozoosper-
mia group, the mean patient age was 37.3 ± 6.0 (range
27–63); in the necrozoospermia group, the mean patient
age was 42.0 ± 2.6 (range 39–44).
Table 1 shows the clinical parameters of the patients
stratified according to SR. With the only exception of
body mass index [BMI, weight (kg)/height (m2)] and
circulating T, all the other parameters differed signifi-
cantly between the patients that experienced successfull
SR compared to those that had unsuccessfull SR, includ-
ing age that was older in the successfull SR group, FSH
and LH whose values were higher in the unsuccessfull
SR group, and testis volume that was lower in the
unsuccessfull SR group.
Table 2 shows the clinical characteristics of the patients
stratified according to histology. The sample size for the
four groups of histological diagnosis was 205 for SCO, 75
MA, 149 HypoS, and 57 NormoS. Spermatozoa were re-
covered in 307 out of the 486 patients (63.17%). 60/205
(29.3%) from SCO, 58/75 (77.3%) from MA, 132/149
(88.6%) from HypoS, 57/57 (100%) from NormoS. The 57
NormoS were either oligozoospermic, necrozoospermic
or cryptozoospermic. With the exception of BMI and T,
all the clinical parameters were significantly different
between the groups. Statistical difference in sperm re-
trieval rate was observed between all the groups with a
pattern of increasing likelihood of SR from SCO to MA,
HypoS and NormoS. The leves of FSH and LH were pro-
gressively lower and testicular volume was higher as much
as the histological appearance was improving.
The univariate logistic regression analysis showed that
four factors were associated with SR including semen
analysis, histology, FSH values and testicular volume
(Table 3A). As expected, the odds to recover spermatozoa
from testicular specimens was significantly higher in both
Table 1 Clinical parameters and histopathological features of
the patients stratified according to the SR
Succesfull SR No SR P
Patients n. 307 179
Age (years) 38.2±7.05 35.4±4.97 < 0.01
BMI (kg/m2) 26.85±6.00 26.51±2.78 NS
FSH (mIU/ml) 15.70±12.22 22.51±12.11 < 0.01
LH (mIU/ml) 6.85±4.86 8.87±5.19 < 0.01
T (ng/ml) 4.57±1.94 4.39±3.11 NS
Testis vol. (right, ml) 9.77±6.46 7.11±4.66 0.010
Testis vol. (left, ml) 9.47±7.41 6.96±3.68 0.021
SCO n. (%) 60 (19.5%) 145 (81%) < 0.01
MA n. (%) 58 (18.9%) 17 (9.5%) < 0.01
HypoS n. (%) 132 (43.0%) 17 (9.5%) < 0.01
NormoS n. (%) 57 (18.6%) 0 (0%) < 0.01
SR sperm retrieval, BMI body mass index, FSH follicle stimulating hormone, LH
luteinizing hormone, T testosterone, SCO Sertoli cell only, MA maturation
arrest, HypoS hypospermatogenesis, NormoS normospermatogenesis, NS
not significant
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criptozoospermic and oligozoospermic patients compared
to azoospermic patients. Analogously, the odds to recover
spermatozoa was higher in MA and hypospermatogenic
testes compared with testicular tissue specimens affected
by SCO. Also significant was the odds of SR for each mIU
increase of circulating FSH and for each ml increase of
testicular volume. The same variables were significantly
associated with the hazard ratio (HR) for time for SR with
the exception of oligo-astenozoospermic versus azoosper-
mic (Table 3B).
Multiple logistic regression analysis of variables, includ-
ing semen and histology for SR and age, semen, serum
FSH and testicular histology for sperm recovery time
revealed that semen and testicular histology were both
found to be significant variables to predict successful SR
(Table 4A) while age, semen, histology and FSH were sig-
nificant variables to predict time for sperm recovery
(Table 4B).
We developed a model for the prediction of SR based
on a score composed of three variables derived from
logistic regression analyses, obtained by summing the
points assigned for each predictor (1 point for SCO, 0.33
points for azoospermia and 0.004 points for each FSH
mIU). The predictive ability of the score was evaluated
by using the area under the ROC curve (Fig. 1) that gave
a value of 0.843 with good discriminative performance.
Therefore, we identified a cut-off value of the score ≤ 1.24
with a calculated specificity of 83.39% and sensitivity of
81.11% as suggestive of a good chance of SR upon further
TESE.
Discussion
One of the major issues to be addressed in the manage-
ment of male infertility by TESE is to have an indicator of
Table 2 Clinical characteristics of the patients and SR rate stratified according to testicular histology
SCO MA HypoS NormoS P
Patients n. 205 75 149 57
Age (years) 35.64±5.42 37.21±6.67 39.05±7.83 37.57±4.50 < 0.01
Azoospermia n. (%) 196 (95.6%) 60 (80.0%) 121 (81.2%) 13 (22.8%) < 0.01
Criptozoospermia n. (%) 7 (3.4%) 10 (13.3%) 6 (4.0%) 17 (29.8%) < 0.01
Oligozoospermia n. (%) 2 (1.0%) 5 (6.7%) 22 (14.8%) 24 (42.1%) < 0.01
Necrozoospermia n. (%) 0 (0%) 0 (0%) 0 (0%) 3 (5.3%) < 0.01
BMI (kg/m2) 25.86±2.90 27.71±3.54 27.66±7.80 25.5±2.42 NS
FSH (mIU/ml) 24.34±11.65 18.15±11.63 12.66±11.60 11.02±8.81 < 0.01
LH (mIU/ml) 9.80±6.00 7.25±4.08 5.63±3.25 5.18±2.90 < 0.01
T (ng/ml) 4.30±2.85 4.40±2.06 4.75±1.87 4.93±2.26 NS
SR 60 (29.3%) 58 (77.3%) 132 (88.6%) 57 (100%) < 0.01
Testis vol. (right, ml) 7.24±4.58 7.75±3.39 11.05±8.52 12.38±5.15 < 0.01
Testis vol. (left, ml) 7.17±4.06 8.23±3.69 10.43±10.44 10.56±3.17 NS
SCO Sertoli cell only, MA maturation arrest, HypoS hypospermatogenesis, NormoS normospermatogenesis, BMI body mass index, FSH follicle stimulating hormone,
LH luteinizing hormone, T testosterone, SR sperm retrieval, NS not significant
Table 3 Predictive factors of sperm recovery (A) and of time for
recovery (B) by cTESE, univariate analysis
A. Sperm recovery
Predictor variable OR 95% Cl P
Seminal fluid
Criptozoospermic vs azoospermic 12.67 4.19–62.31 < 0.01
Oligo-astenozoospermic vs
azoospermic
28.80 7.69–
256.10
< 0.01
Histology
MA vs SCO 8.04 4.44–15.19 < 0.01
HypoS vs SCO 18.21 10.41–
33.49
< 0.01
FSH 0.96/
mIU
0.94–0.97 < 0.01
Testis volume 1.05/ml 1.01–1.11 0.013
B. Time for sperm recovery
Predictor variable HR 95% Cl P
Age 1.06/
year
1.04–1.08 < 0.01
Seminal fluid
Criptozoospermic vs azoospermic 3.34 2.05–5.45 < 0.01
Oligozoospermic vs azoospermic 6.64 0.88–46.15 NS
Histology
MA vs SCO 4.61 2.84–7.49 < 0.01
HypoS vs SCO 9.10 6.03–13.74 < 0.01
FSH 0.95/
mIU
0.93–0.96 < 0.01
Testis volume 1.02/ml 1.01–1.04 < 0.01
OR odds ratio, HR hazard ratio, FSH follicle stimulating hormone, SCO Sertoli
cell only, MA maturation arrest, HypoS hypospermatogenesis, NS not significant
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the likelihood of recovery of sperm from the testis. This
information is important for the couple to make a
thoughtful choice about whether or not to undertake an
in vitro fertilization procedure that can cause physical,
psychological and financial consequences. It has recently
been called into question the validity of predictive
indicators of recovery of sperm from the testes of patients
suffering from NOA, in particular the usefulness of
diagnostic testicular biopsy [3–7]. The criticisms to the
procedure are mainly based on two considerations. The
first is that the histological appearance of a bioptic speci-
men does not mirror the condition of the testicular paren-
chyma as a whole and therefore it is not worth referring
the patient to biopsy because even severe histological
features such as SCO, do not rule out the presence of
portions of tissue with intact spermatogenesis, generating
false negatives. The second is that the mTESE, according
to the proponents of the technique, substantially lowers
the risk of not detecting preserved spermatogenesis areas,
if present, ensuring almost total certainty of potential
sperm recovery, reducing significantly the usefulness of
diagnostic biopsy. These arguments have, in turn, limita-
tions. It is clear that whatever the procedure, either diag-
nostic or therapeutic, it will never provide the absolute
certainty of the absence of germ cells for fertilization,
because in no case the entire tissue can be analized and
Fig. 1 ROC curve of pertinent parameters to discriminate successful and failed cTESE (AUC = 0.843). ROC = Receiver operating characteristic; cTESE =
conventional testicular sperm extraction; AUC = area under a curve
Table 4 Predictive factors of sperm recovery (A) and of time for
recovery (B) by cTESE, multivariate analysis
A. Sperm recovery
Predictor variable OR 95% Cl P
Seminal fluid
Criptozoospermic vs azoospermic 8.00 2.24–42.64 < 0.01
Oligozoospermic vs azoospermic 6.55 1.56–63.11 < 0.01
Histology
MA vs SCO 6.94 3.77–13.30 < 0.01
HypoS vs SCO 16.44 9.31–30.54 < 0.01
B. Time for sperm recovery
Predictor variable HR 95% Cl P
Age 1.05/year 1.02–1.07 < 0.01
Seminal fluid
Criptozoospermic vs azoospermic 1.51 0.87–2.62 NS
Oligozoospermic vs azoospermic 2.05 1.25–3.37 < 0.01
Histology
MA vs SCO 4.07 2.36–7.02 < 0.01
HypoS vs SCO 6.60 3.96–10.99 < 0.01
FSH 0.98/mIU 0.96–0.99 0.030
OR odds ratio, HR hazard ratio, FSH follicle stimulating hormone, SCO Sertoli
cell only, MA maturation arrest, HypoS hypospermatogenesis, NS not significant
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the risk not to identify areas of tissue with intact sperm-
atogenesis can not be eliminated. It is not clear, moreover,
what is the real advantage of the mTESE in terms of
recovery compared with cTESE because recent studies
have not confirmed its superiority in all circumstances [8,
9, 14, 15]. Although, pseudo-randomized prospective data
show more favourable sperm retrieval in NOA for mTESE
compared to cTESE, especially in histological patterns of
patchy spermatogenesis such as SCO, in patients with
uniform histological patterns such as MA, the outcome of
mTESE seems less favourable [14]. No secure clinical
predictors of sperm retrieval are demonstrated for both
procedures and clinical complication rate seems not to
differ according to a systematic review [14]. A further
systematic review with meta-analysis took into consider-
ation fifteen studies with a total of 1890 patients [15]. In a
direct comparison, performance of mTESE was 1.5 times
more likely (95% confidence interval 1.4–1.6) to result in
successful SR as compared with cTESE. The essential
weakness of the studies and meta-analysis on mTESE is
the lack of proper control groups. Also the studies com-
paring the success rate of mTESE against cTESE should
be viewed with caution because due to the extreme vari-
ability of the spermatogenic process, clearly visible also in
patients with normal spermatogenesis (seminal parame-
ters in normozoospermic patient may vary profoundly a
few days away), the success or failure of SR can change
significantly from day to day.
There are only few exceptions to this methodological
limit, namely studies in which both mTESE and cTESE
were performed during the same recovery procedure in
the same patient in comparison studies. Franco et al.
showed that the outcome of mTESE did not improve SR
as compared to single cTESE biopsy on the same testicle
or to multiple contralateral cTESE [8]. Analogously,
Marconi and colleagues found no difference between
mTESE and cTESE in terms of sperm retrieval rates [9].
Whatever the best technique to recover spermatozoa,
the opportunity to offer to both doctors and patients a
likely indicator of success of SR rate is important. A situ-
ation that can occur in case of reoperation following a
failure of TESE, provided that the information coming
from the microscopic analysis of a testicular fragment
is available.
The evidence for success rates of repeat sperm re-
trieval surgery in men with NOA is based on a very
small number of retrospective case series with varying
patient selection criteria and methodologies. The success
rate of repeat TESE varied from 30% [16] to 41.6% in
the first repeat attempt and the success rate increased to
100% for two patients with six attempts [17], there are
limitations of this evidence as only 2 out of 628 patients
in the study reached six attempts, hence it is difficult
to generalise.
One retrospective case series of repeat mTESE showed
a success rate of 82% [18]. The study identified lower
FSH level and larger testicular volume to have a predict-
ive value in determining the success of a second attempt.
The findings of the study are limited by its retrospective,
nonrandomized, non-controlled nature. In summary,
there is low level evidence from retrospective case series
that the cumulative success rate of repeat sperm re-
trieval increases with increasing numbers of attempts
and is higher in males who have had a previous success-
ful attempt. The results are not substantiated by other
studies, hence the replicability of these results in other
patients or settings is limited. These considerations sub-
stantiate the utility of the testicular biopsy, togheter with
other potential predictors of SR, in dealing with assisted
reproductive techniques that require TESE when further
attempts of TESE are planned. Accordingly, our data
suggest not to miss the opportunity to collect a testicular
fragment in the course of TESE to perform histologic
analysis. Clearly, histology should not be included as a
predictive factor of SR at first TESE attempt since the
TESE specimen, either conventional or micro, not a
prior pure diagnostic biopsy is what is read for histology
and a patient will know of succesful sperm retrieval
before histology results are even available. Nevertheless,
the diagnostic biopsy during cTESE or even mTESE,
along with other indicators may help to make an
informed choice in the hypothesis of a subsequent new
attempt of SR. Therefore, the allegation that it is time to
put testis biopsy aside as a technique of historical inter-
est not relevant to current reproductive technologies
should be called into question and the opportunity to
collect a testicular specimen for histology during the
course of TESE, for a better stratification of the SR
chance in case of a subsequent attempt following a
failure, should be taken. Accordingly, recent published
evidences support the reliabilty of diagnostic biopsy as a
predictor of positive sperm retrieval in men with
NOA [19–23].
By performing TESE, the laboratory personnel should
allow themselves enough time to dissect the testicular
tissue and retrieve the sperm, particularly in the case of
NOA patients, for whom spermatogenesis may be se-
verely impacted and in whom it may take a long time to
find sperm in the tissue [24]. Interestingly, the data pre-
sented here provide an estimate of what factors are ex-
pected to make sperm retrieval faster or slower. As
expected, age, worst semen and histology and higher
FSH values were all negative predictive factors in the
multivariate analysis.
Our study does have limitations. Most importantly, a
control population of men who were submitted to
mTESE was not available. Other limitation includes the
retrospective nature of the study.
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Conclusions
Our data enable to construct a score which helps to
provide a good approximation of the probability of SR
with cTESE in case of reoperation because of failure in
recovery of sperm, provided that a biopsy for micro-
scopic analysis is harvested during the first TESE at-
tempt. The biopsy, along with other parameters, enables
a customization of the prognosis that would otherwise
rely solely on literature data that often extend over a
very wide range and still have the limitation of being
strongly influenced by skill or experience of the team
that created them and does not apply to all the peculiar
situations that can bump into real life. Providing patients
with a personalized, more clinically meaningful estimate
of their likelihood of SR can aid in counseling and de-
crease anxiety for the patient and treating physician.
Furthermore, consideration should be given to the vari-
ables found to be involved into the time required for
sperm recovery. This individualized estimate is likely to
improve the complex organisation of assisted reproduct-
ive technology procedures that may require multiple at-
tempts, including repeated TESE.
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